Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 4, Pages e35130
Publisher
Public Library of Science (PLoS)
Online
2012-04-20
DOI
10.1371/journal.pone.0035130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis
- (2011) Y. Gao et al. CANCER RESEARCH
- Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
- (2011) Patrick J. Grohar et al. JNCI-Journal of the National Cancer Institute
- DNA Binding Characteristics of Mithramycin and Chromomycin Analogues Obtained by Combinatorial Biosynthesis
- (2010) Francisca Barceló et al. BIOCHEMISTRY
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
- (2010) Sean M. Post et al. CANCER CELL
- Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity
- (2010) Z. Jia et al. CANCER RESEARCH
- A sensitive polymerase chain reaction-based method for detection and quantification of metastasis in human xenograft mouse models
- (2010) Anastasia Malek et al. CLINICAL & EXPERIMENTAL METASTASIS
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts
- (2010) Sara Previdi et al. GYNECOLOGIC ONCOLOGY
- Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation
- (2010) Indira Jutooru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a
- (2010) I. Jutooru et al. MOLECULAR PHARMACOLOGY
- ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
- (2010) Paolo Kunderfranco et al. PLoS One
- Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met
- (2009) S. Papineni et al. CARCINOGENESIS
- Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells
- (2009) Sara Napoli et al. EMBO JOURNAL
- Inhibitory effect of acetyl-11-keto-β-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells
- (2008) Hui-Qing Yuan et al. BIOCHEMICAL PHARMACOLOGY
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
- (2008) G. Chadalapaka et al. CANCER RESEARCH
- Generation of New Derivatives of the Antitumor Antibiotic Mithramycin by Altering the Glycosylation Pattern through Combinatorial Biosynthesis
- (2008) María Pérez et al. CHEMBIOCHEM
- Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
- (2008) Jamin A. Willoughby et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started